Incorporating therapeutic drug monitoring into the World Health Organization hierarchy of tuberculosis diagnostics

Eur Respir J. 2016 Jun;47(6):1867-9. doi: 10.1183/13993003.00040-2016. Epub 2016 Mar 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents* / administration & dosage
  • Antitubercular Agents* / adverse effects
  • Antitubercular Agents* / pharmacokinetics
  • Drug Monitoring / methods*
  • Humans
  • Medication Therapy Management / organization & administration
  • Pharmacovigilance
  • Tuberculosis* / diagnosis
  • Tuberculosis* / drug therapy
  • World Health Organization

Substances

  • Antitubercular Agents